Investor calendar

Silent period

29 August 2023–27 September 2023

Possible request from a shareholder to have a matter included on the agenda of the Annual General Meeting 2023*
28 September 2023

Financial statements release for financial year 2022–2023

28 September 2023

Annual report for financial year 2022–2023

Week 42/2023

Annual General Meeting 2023

16 November 2023

Silent period

6 February 2024–6 March 2024

Half-year financial report 1 July–31 December 2023

7 March 2024

Nightingale Health's financial year is from 1 July to 30 June.

*for further instructions, please see Annual General Meeting 2023

Silent period

30 August 2022–28 September 2022

Possible request from a shareholder to have a matter included on the agenda of the Annual General Meeting 2022*

29 September 2022

Financial statements release for financial year 2021–2022

29 September 2022

Unaudited consolidated IFRS financial statements for financial year 2020-2021 and most significant impacts of FAS-IFRS transition
Approximately 25 October 2022

IFRS-compliant consolidated financial statements and annual report for financial year 2021–2022
Approximately 27 October 2022

Annual General Meeting 2022

17 November 2022

Silent period

21 February 2023–22 March 2023

Publication of comparative IFRS information for the half-year periods ended on 31 December 2021 and 30 June 2022

22 March 2023

Half-year financial report 1 July–31 December 2022

23 March 2023

Nightingale Health's financial year is from 1 July to 30 June.

*for further instructions, please see Annual General Meeting 2022

Silent period

16 August 2021–14 September 2021

Possible request from a shareholder to have a matter included on the agenda of the Annual General Meeting 2021*

8 September 2021

Financial statements release for financial year 2020–2021

15 September 2021

Annual report for financial year 2020–2021

Week 39/2021

Annual General Meeting 2021

28 October 2021

Silent period

25 January 2022–23 February 2022

Half-year financial report 1 July– 31 December 2021

24 February 2022

Nightingale Health's financial year is from 1 July to 30 June.

*for further instructions, please see AGM 2021

Nightingale applies a restricted period of thirty (30) calendar days before the publication, as well as the day of the publication, of a half-year financial report or financial statements release (“closed window”). During this period, the management (Board of Directors, the CEO, and other members of the Management Team), other persons defined by the company as subject to trading restrictions, and any legally incompetent persons under their custody are prohibited to conduct any transactions, on its own account or for the account of a third party, directly or indirectly, relating to the company’s shares or debt instruments, or derivatives or other financial instruments linked thereto. In addition to the company’s management, the closed window applies to Nightingale’s employees who contribute to the preparation of the company’s financial reports or who have access to information pertaining to this.

Nightingale adheres to a 30-day silent period before the publication of a half-year financial report or financial statements release. During this time, the company will not give comments to the media or other parties on the company’s financial position, markets or future outlook. During the silent period, the company will not meet with capital markets representatives.

If an event during the silent period requires immediate publication, Nightingale will publish the information without delay in accordance with regulations regarding the disclosure obligation and can comment on the matter in question.